Role of Virechana and Neelakantha Rasa as Rasayana with Phalatrikadi Kwatha Anupana in Madhumeha (DM2) - A Single Case Study
Abstract
Madumeha is a progressive both Avaranajanya and Dhatukshayajanya Vyadhi[1] it is correlated with diabetes mellitus, with the involvement of Tridosha. Diabetes mellitus is a metabolic, autoimmune, stress induced impaired hyperglycemia. It is due to either deficiency of insulin or combination of insulin resistance and inadequate insulin secretion. Virechana and Rasarasayana Yogas are stated as the best in Madhumeha. In the present study Virechana was selected. For Deepana Pachana, Abhayadi Kwatha was selected, Snehana was done with Murchita Sarshapa Taila, during Vishramakaala, Sarvanga Abhyanga was done with Murchita Sarshapa Taila and Baspa Sweda was done for 3 days. Virechana was given with Vishalapippali Yoga, followed by Rasarasayana Yoga, Neelakantha Rasa with Phalatrikadi Kwatha. Result showed that, there was very good improvement in the subjective parameters and objective parameter, FBS was reduced from 102.7 mg/dl to 98 mg/dl. PPBS were reduced from 145.6 mg/dl to 132 mg/dl. HbA1C was reduced from 8.4% to 5.8% after the intervention. In the contest of Madhumeha Chikitsa, Virechana is highlighted. In practice the newly diagnosed case of Madhumeha is reversible with timely Ayurvedic classical intervention. A significant improvement, in subjective and objective parameter of Madhumeha (DM2) has made it necessary to make a single case study.
Downloads
References
Acharya JT, ed. Charaka Samhita of Agnivesha with Chakrapani Datta's Ayurveda Deepika. 5th ed. Varanasi: Chaukhamba Sanskrit Sansthan; 2001. Indriya 9/8. p. 368.
Vagbhata. Ashtanga Hridayam with Sarvangasundara and Ayurveda Rasayana Commentary by Arundutta and Hemadri. Paradkara HS, editor. Nidana Sthana, 10th Adhyaya, Verse 18.
Sushruta Samhita. Sridalhanacharya Rachita, Teeka. Sutra Sthana, Chapter 24, Verse 9. Varanasi: Chaukamba Publications; p. 116.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, On behalf of the IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.
Diabetes, Pre-diabetes and Metabolic Syndrome. Canadian Journal of Diabetes. 2013;37: S8-S11. Available from: www.canadianjournalofdiabetes.com. Accessed on March 2, 2019.
Bharata Bhaishajya Ratnakara. Pratama Bhaga. Rasavaidya Naaginadas Shaaha Sangrahita. Vyakyakara Bhishakratna Gopinath Gupta, Samshodaka Kaviraj Nivaranaachandra Bhattacharya, Akara Kahaya Kalpana. Varanasi: Chaukamba Publications; p. 10.
Shree Govindadaasa virachita Bhishagratna Bhramhashankara misrina Pariskruta Parivardhira Bhaishajya Ratnavali. Vyakyakara Kaviraja Sri Ambhikaadattashatri Ayurvedacharya. 5th chapter, Ata Jwarachikitsaprakranam, Sloka 1288-1289. Varanasi: Chaukamba Publications; p. 186.
Shree Govindadaasavirachita Bhishagratna Bhramhashankaramisrina Pariskruta Parivardhira Bhaishajya Ratnavali. Vyakyakara Kaviraja Sri Ambhikaadattashatri Ayurvedacharya. Rasayana Prakarana, Sloka 61-65. Varanasi: Chaukamba Publications; p. 1108.
Shreematpadita damodara Soonu-Shaarangadharar acharya virachita Sharangadara Samhita. Prabhodini Hindi Teeka. Madyama Kanda Adyaya 2, Kwakalpana Sloka 209. Varanasi: Chaukamba Publications; p. 192.
Copyright (c) 2024 Narasareddy, Madhava Diggavi, Fareeda Begum Shaikh, Ramaling Hugar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.